Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

ClinicalTrials.gov ID: NCT00528866

Public ClinicalTrials.gov record NCT00528866. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Adjuvant 3DCRT/IMRT in Combination With Androgen Suppression and Docetaxel for High Risk Prostate Cancer Patients Post-Prostatectomy: A Phase II Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Specialized radiation therapy that delivers a high-dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as leuprolide, goserelin, flutamide, or bicalutamide, may lessen the amount of androgens made by the body. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving radiation therapy together with androgen suppression and docetaxel after surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying how well giving radiation therapy together with androgen suppression and docetaxel works in treating patients with high risk prostate cancer who have undergone radical prostatectomy.

Study identification

NCT ID
NCT00528866
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
80 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2008 (Actual)
Primary completion
Dec 2013 (Actual)
Completion
May 14, 2018 (Actual)
Last update posted
Apr 24, 2019

2008 – 2018

United States locations

U.S. sites
69
U.S. states
24
U.S. cities
63
Facility City State ZIP Site status
Arizona Oncology Services Foundation Phoenix Arizona 85013 —
Auburn Radiation Oncology Auburn California 95603 —
Radiation Oncology Centers - Cameron Park Cameron Park California 95682 —
Mercy Cancer Center at Mercy San Juan Medical Center Carmichael California 95608 —
Radiation Oncology Center - Roseville Roseville California 95661 —
Radiological Associates of Sacramento Medical Group, Incorporated Sacramento California 95815 —
Mercy General Hospital Sacramento California 95819 —
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94115 —
Solano Radiation Oncology Center Vacaville California 95687 —
Urology Center of Colorado Denver Colorado 80211 —
Poudre Valley Radiation Oncology Fort Collins Colorado 80528 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Cancer Institute at St. John's Hospital Springfield Illinois 62702 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Norton Suburban Hospital Louisville Kentucky 40207 —
Tulane Cancer Center Office of Clinical Research Alexandria Louisiana 71315-3198 —
Mary Bird Perkins Cancer Center - Baton Rouge Baton Rouge Louisiana 70809 —
MBCCOP - LSU Health Sciences Center New Orleans Louisiana 70112 —
CCOP - Ochsner New Orleans Louisiana 70121 —
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore Maryland 21201 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River Massachusetts 02721 —
Josephine Ford Cancer Center at Henry Ford Hospital Detroit Michigan 48202 —
Fairview Ridges Hospital Burnsville Minnesota 55337 —
Mercy and Unity Cancer Center at Mercy Hospital Coon Rapids Minnesota 55433 —
Fairview Southdale Hospital Edina Minnesota 55435 —
Mercy and Unity Cancer Center at Unity Hospital Fridley Minnesota 55432 —
Minnesota Oncology Hematology, PA - Maplewood Maplewood Minnesota 55109 —
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital Minneapolis Minnesota 55407 —
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center Robbinsdale Minnesota 55422-2900 —
CentraCare Clinic - River Campus Saint Cloud Minnesota 56303 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
United Hospital Saint Paul Minnesota 55102 —
Ridgeview Medical Center Waconia Minnesota 55387 —
Regional Cancer Center at Singing River Hospital Pascagoula Mississippi 39581 —
Cancer Institute of Cape Girardeau, LLC Cape Girardeau Missouri 63703 —
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St Louis Missouri 63110 —
Nevada Cancer Institute Las Vegas Nevada 89135 —
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton Marlton New Jersey 08053 —
Newark Beth Israel Medical Center Newark New Jersey 07112 —
University Medical Center at Princeton Princeton New Jersey 08540-3298 —
Mission Hospitals - Memorial Campus Asheville North Carolina 28801 —
Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina 28233-3549 —
Wayne Radiation Oncology Goldsboro North Carolina 27534 —
Pardee Memorial Hospital Hendersonville North Carolina 28791 —
Cancer Centers of North Carolina - Raleigh Raleigh North Carolina 27607 —
Forsyth Regional Cancer Center at Forsyth Medical Center Winston-Salem North Carolina 27103 —
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096 —
Summa Center for Cancer Care at Akron City Hospital Akron Ohio 44309-2090 —
Barberton Citizens Hospital Barberton Ohio 44203 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267 —
Cancer Care Center, Incorporated Salem Ohio 44460 —
Precision Radiotherapy at University Pointe West Chester Ohio 45069 —
Cancer Treatment Center Wooster Ohio 44691 —
Oklahoma University Cancer Institute Oklahoma City Oklahoma 73104 —
Integris Oncology Services Oklahoma City Oklahoma 73112 —
St. Luke's Cancer Network at St. Luke's Hospital Bethlehem Pennsylvania 18015 —
Delaware County Regional Cancer Center at Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026 —
Fox Chase Cancer Center Buckingham Furlong Pennsylvania 18925 —
Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania 19111-2497 —
Fox Chase Cancer Center CCOP Research Base Philadelphia Pennsylvania 19140 —
Crozer-Chester Medical Center Upland Pennsylvania 19013 —
CCOP - Upstate Carolina Spartanburg South Carolina 29303 —
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg South Carolina 29303 —
Rapid City Regional Hospital Rapid City South Dakota 57701 —
Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray Utah 84157 —
CCOP - Virginia Mason Research Center Seattle Washington 98101 —
Community Memorial Hospital Cancer Care Center Menomonee Falls Wisconsin 53051 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00528866, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 24, 2019 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00528866 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →